Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 43

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 43
---
|:----|:---------------------------------|--------:|:--|:----|:-----|---------:|:--|:----|:-----|-----------:|:--|
| Net cash (used in) provided by operating activities from discontinued            
 operations                                                                       |     | $                                |  (9,155 | ) |     | $    |  295,967 |   |     | $    | (1,439,028 | ) |
| Net cash used in investing activities from discontinued operations               |     | $                                |  (3,148 | ) |     | $    |        - |   |     | $    |    (21,542 | ) |
| Net cash provided by (used in) financing activities from discontinued operations |     | $                                | 256,088 |   |     | $    | (371,888 | ) |     | $    |  1,480,803 |   |

Note 6 – Acquisition of Fortress Cove

On May 6, 2024, EUDA entered into a Share Purchase Agreement with certain persons for the acquisition of all outstanding shares of Fortress Cove and its 100% owned subsidiary, CKHP.

CKHP is a Malaysia company, and it has no operations prior to April 1, 2024 other than start up activities. On March 11, 2024, CKHP signed an agency contract to begin its principal activities, which include the exclusive rights in the distribution of series of collagens of “YOROYAL” brand in Malaysia, Vietnam and Indonesia, through its members and through its online platform. On March 25, 2024, CKHP signed another agency contract which include the exclusive distribution rights to distribute bioenergy cabins in Malaysia from Guangzhou Beauty Wellness Health Technology Co., Ltd. (“GBHT”). Pursuant to the Share Purchase Agreement, EUDA has agreed to acquire the entire issued capital of CKHP for an aggregate consideration of 8,571,428newly issued ordinary shares (the “Consideration Shares”), valued at $ 15.0million, or $ 1.75per share based on market price on May 7, 2024, EST. An additional one million ordinary shares (the “Additional Consideration Shares”) will be issued to the persons named in the Share Purchase Agreement if CKHP’s net income for the year ended December 31, 2024 is at least USD 2.0million and net income for the year ended December